In a nutshell This study compared the Mediterranean diet (MD) with the low-fat diet (LFD) in patients with coronary artery disease (CAD). It found that after 3 months the MD was associated with higher omega-3 levels than the LFD. Some background Cholesterol is the name commonly used for the fats in the blood. Cholesterol can block the...
Read More
In a nutshell This study looked at how beta-blockers affected patients following a heart attack. It found that patients using a low dose of beta-blockers had better outcomes one year later. Some background Following a heart attack, there are several treatment options available to improve outcomes. One treatment is beta-blockers (BBs), which prevent...
Read More
In a nutshell This study evaluated whether antiplatelet therapy after percutaneous coronary intervention (PCI) should be given personalized for each patient. It found that guided therapy resulted in a reduction in the overall risk of heart attack, stroke, and death compared to standard therapy. Some background Percutaneous coronary...
Read More
In a nutshell This study looked at which antiplatelet drug is better in patients who had percutaneous coronary intervention (PCI). It found that patients who had maintenance treatment with clopidogrel (Plavix) were less likely to suffer from a heart attack, bleeding, stroke, or death over the following 24 months compared to those...
Read More
In a nutshell This study compared two heart interventions for people with coronary heart disease and type 2 diabetes (T2D). It found that coronary artery bypass grafting (CABG) led to better long-term outcomes than placing a stent in these patients. Some background Coronary heart disease (CHD) is a condition in which the arteries which supply blood to...
Read More
In a nutshell This trial compared outcomes for sirolimus-eluting biodegradable stents (Orsiro) to everolimus-releasing durable stents (Xience) in patients with a need for more than 1 stent. It found that for patients having several stents placed after a heart attack, biodegradable stents had better outcomes. Some background While all heart...
Read More
In a nutshell This study evaluated the long-term effects of rosuvastatin (Crestor) compared to placebo in reducing heart complications. This study concluded that rosuvastatin helped lower the risk of major cardiovascular events (MACE) in the long-term. Some background Most MACEs such as heart attack and stroke happen in people who do...
Read More
In a nutshell This study looked at the use of the flu vaccine in patients with heart disease. It found that patients who had the flu vaccine were more likely to have better cardiovascular outcomes. Some background The flu can be especially dangerous for patients with heart disease. It can lead to further heart disease or even death. The...
Read More
In a nutshell This study compared the treatment of stable ischemic heart disease (SIHD) with percutaneous coronary angioplasty (PCI) or with medication alone. It found that the risk of mortality was the same in both groups. Some background Coronary artery disease (CAD) is when the blood vessels in the heart become blocked and the heart muscle...
Read More
In a nutshell This study looked at the use of colchicine (Colcrys) in the treatment of coronary artery disease (CAD). It found that patients treated with colchicine had a lower risk of heart attack, stroke, or heart disease-related death. Some background CAD is a disease in which the blood vessels in the heart become blocked. It can...
Read More
In a nutshell This study compared the rate and duration of COVID-19 infection in patients taking aspirin compared to those not taking this drug. They found that patients taking aspirin were less likely to get COVID-19 infection and had a lower duration of disease compared to those not taking aspirin. Some background Aspirin is...
Read More
In a nutshell This study compared the use of two beta-blockers, carvedilol (Coreg) and metoprolol (Lopressor), after a heart attack. It found that they had similar results on most patient groups. However, carvedilol improved survival in patients with reduced heart function. Some background Beta-blockers are a group of medications that...
Read More
